Neuronetics, Inc. logo

STIM Earnings Date: Nov 4, 2026 (Estimated) — Neuronetics, Inc.

NASDAQ · Healthcare · Medical Devices

Updated

Price $2.25
Market Cap $171.1M
P/E -4.9
52W Range $0.80 – $3.44
Next Earnings · Before open (est.)

When is STIM's next earnings date?

Neuronetics, Inc. (STIM) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.08 on revenue of $40.4M.

How did STIM do in its last earnings report?

In its most recent report on Aug 11, 2026 (Q2 2026), Neuronetics, Inc. posted EPS of -$0.05 versus the -$0.12 estimate, a beat of 58.3%. Revenue was $41.6M against a $40.2M estimate. The stock's 1-day post-earnings move was +47.0%.

How much does STIM stock move after earnings?

STIM beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 15.8% (up or down) in the day after earnings.

About Neuronetics, Inc.

Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-08-11Q2 2026-0.12-0.05+58.33%$41.6M✅ Beat+47.00%+50.69%+40.09%
2026-05-05Q1 2026-0.17-0.16+5.88%$34.5M✅ Beat+7.43%-25.50%-31.19%
2026-03-17Q4 2025-0.11-0.10+9.09%$41.8M✅ Beat-9.93%+17.65%+2.21%
2025-11-04Q3 2025-0.12-0.13-8.33%$37.3M❌ Miss+3.61%-22.74%-51.62%
2025-08-05Q2 2025-0.08-0.15-87.50%$38.1M❌ Miss-2.47%-15.88%-29.83%
2025-05-06Q1 2025-0.12-0.21-75.00%$32.0M❌ Miss+0.00%-8.00%-13.78%
2025-03-04Q4 2024-0.24-0.33-37.50%$22.5M❌ Miss+18.78%+1.64%-11.27%
2024-11-12Q3 2024-0.23-0.29-26.09%$18.5M❌ Miss-37.27%-29.00%+9.09%

Showing last 8 quarters.

Revenue by segment & region

By segment

Q2 FY26 · $41.6M total

SegmentShareRevenueYoY
Service64.7%$26.9M—
Product35.3%$14.7M—

Source: company filings via FMP. YoY compares the same fiscal period a year earlier.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .